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c I. Department of Rheumatology, National Institute of Rheumatology and Physiotherapy; Frankel Leó út 62., H-1023, Budapest, Hungary 
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A B S T R A C T   
Background: The capability approach has received increasing attention in wellbeing measurement in the past 
years, but it has still remained an underexplored area in musculoskeletal (MSK) health. 
Objective: We aimed to explore the capability wellbeing in relation to MSK health, by measuring the associations 
between the Health Assessment Questionnaire Disability Index (HAQ-DI) physical functioning and the ICECAP-A 
and ICECAP-O capability wellbeing measures. 
Design: A cross-sectional survey was performed in 2019 on a representative sample of the Hungarian general 
adult population. 
Method: Capability wellbeing was measured by the ICECAP-A (age-group 18–64) and ICECAP-O (age group 65+) 
questionnaires. MSK health was defined by the HAQ-DI, the mobility domain of the EQ-5D-3L/-5L health status 
measures, self-reported walking problems and MSK diagnosis (neck/back/low back defects, hip/knee arthrosis, 
osteoporosis). 
Results: Altogether 2021 individuals (female: 50.1%) participated in the survey with mean (SD) age of 48.7 (17.9) 
years and HAQ-DI of 0.138 (0.390). ICECAP-A (N = 1568, 77.6%) and ICECAP-O (N = 453, 22.4%) scores were 
on average (SD) 0.894 (0.126) and 0.828 (0.150), respectively. Spearman correlations between the HAQ-DI and 
ICECAP-A/-O index scores were moderate (r = − 0.303 and − 0.496; p < 0.05). Both the ICECAP-A/-O index 
scores differed significantly (ANOVA test, p < 0.05) across all MSK subgroups. In the ordinary least square re-
gressions, marginal effects of ICECAP-A/-O scores on HAQ-DI were significant (− 0.149 and − 0.123) when 
controlling for socio-demographic characteristics. 
Conclusions: MSK health problems are associated with lower capability wellbeing. ICECAP-A/-O might capture 
effects of MSK conditions not measured by the HAQ-DI or the EQ-5D-5L. Further studies should test these as-
sociations in disease-specific samples.   
1. Introduction 
The prevalence of musculoskeletal (MSK) diseases is on the rise 
worldwide and is expected to increase even further in the future, causing 
substantial disability and burden on individuals and societies (Sebbag 
et al., 2019). According to the Global Burden of Diseases, Injuries and 
Risk Factors Study 2019, the number of people living with MSK 
conditions was about 1.714 billion worldwide and an increasing ten-
dency (62% in average) has been observed in all MSK groups since 1990 
(Cieza et al., 2021). The most prevalent MSK disorders were low back 
pain, fractures and osteoarthritis, and MSK disorders contributed in total 
to 149 million years of life lived with disability. 
The measurement of patient reported outcomes and health-related 
quality of life (HRQoL) has become the cornerstone of medical 
* Corresponding author. Health Economics Research Center University Research and Innovation Center Óbuda University, 96/B Bécsi út, 1034, Budapest, Hungary. 
E-mail address: pentek.marta@uni-obuda.hu (M. Péntek).  
Contents lists available at ScienceDirect 
Musculoskeletal Science and Practice 
journal homepage: www.elsevier.com/locate/msksp 
https://doi.org/10.1016/j.msksp.2021.102420 
Received 2 March 2021; Received in revised form 26 May 2021; Accepted 26 June 2021   
Musculoskeletal Science and Practice 55 (2021) 102420
2
decision making in the care of patients with MSK diseases (Fernandes 
et al., 2013; Smolen et al., 2017). These outcomes can provide an insight 
into the disease burden caused by the disease and the effects of the 
treatment across the physical, mental and social domains of health from 
the patients’ perspective. Wellbeing is related to HRQoL, however, it 
assesses the person’s life in a broader sense, covering aspects like 
happiness, satisfaction or capabilities. The measurement of wellbeing is 
especially important for the planning and the evaluation of in-
terventions that are aiming not so much at improving health, but 
increasing wellbeing. This includes, for instance, rehabilitation, various 
social care or long-term care interventions (Woods, 2005; Scoglio et al., 
2019; Bauer et al., 2021). Therefore, wellbeing measures are particu-
larly relevant in chronic MSK disorders. 
In the assessment of wellbeing, a relatively new framework, the 
capability approach has gained momentum in the past years (Sen and 
Nussbaum, 1993; Coast et al., 2008). The ICECAP-O was one of the first 
capability-based measures of wellbeing developed for the elderly, which 
was followed by the ICECAP-A for adults and by further ICECAP in-
struments (Flynn et al., 2011; Al-Janabi et al., 2012). Tariff values have 
been elicited both for the ICECAP-A and –O in the UK, reflecting societal 
preferences, the value people attach to each level of the five domains 
covered by these measures (Coast et al., 2008; Flynn et al., 2015). 
Therefore, the ICECAP-A/-O can also be used for economic evaluations 
to evaluate the benefits of interventions targeting wellbeing beyond 
health. The growing importance of the capability approach is shown by 
the fact that the guideline of the National Institute for Health and Care 
Excellence in the UK recommends the use of capability measures, 
including ICECAP, for the evaluation of social care (NICE, 2013). 
Nonetheless, the use of ICECAP measures has not yet spread in the 
field of MSK diseases and little is known about the burden that MSK 
health problems pose on patients’ capability wellbeing. Moreover, the 
relationship between the physical functional status and the capability 
wellbeing has remained underexplored so far (Afentou and Kinghorn, 
2020; Proud et al., 2019). The Health Assessment Questionnaire 
Disability Index (HAQ-DI) has been originally developed to assess the 
physical functional status in multiple illnesses (Bruce and Fries, 2003). It 
is one of the most widely applied measure of functioning and disability 
across rheumatic diseases, and it has been successfully used also in the 
general population (Carmona et al., 2001; Krishnan et al., 2004; Sokka 
et al., 2004, 2006; Chandratre et al., 2013; Rose et al., 2014; Jennings 
et al., 2015; Ramadass et al., 2018). The relationship between HAQ-DI 
and generic health status measures, such as the EQ-5D or the SF-36 
has been assessed in various MSK conditions (e.g. rheumatoid 
arthritis, psoriatic arthritis, osteoarthritis, gout) (Chandratre et al., 
2013; van Groen et al., 2010; Pennington and Davis, 2014; Leung et al., 
2020). However, the relationship between the HAQ-DI and ICECAP 
measures has not yet been investigated. Diseases-specific studies are 
undoubtedly needed to fill in this gap, however population-based 
studies focusing on MSK symptoms would allow to capture MSK 
health in a wider context and also could involve individuals living with 
MSK symptoms but without having a well-defined diagnosis. 
The aim of our study was, therefore, to explore the capability well-
being in relation to MSK health in the general population and analyze its 
determinants. Our primary focus is on the associations between the 
HAQ-DI and ICECAP-A/-O measures. Secondarily, we consider mobility 
problems reported on the EQ-5D-3L and EQ-5D-5L generic health status 
measures and the relevant questions (walking problems, self-reported 
MSK diagnoses) adapted from the questionnaire of the European 
Health Interview Survey (EHIS) (EuroQol, 1990; Herdman et al., 2011; 
Eurostat European Health, 2020). 
2. Materials and methods 
2.1. Study design and participants 
In May–June of 2019, a population-based, cross-sectional computer- 
assisted personal interview survey was performed among the adult 
general population (aged 18 and over) of Hungary. Recruitment of re-
spondents (random walk door-to-door recruitment method, target 
sample size N = 2000) and interviews were conducted by a market 
survey company (New Land Media Kft.) using random sampling method. 
Individuals aged 18 and over who provided informed consent were 
eligible to participate in the study. To ensure representativeness, quota 
sampling method was applied. Predefined quotas by sex, age-group, 
settlement type and geographic region were set based on national pop-
ulation statistics. All human studies have been approved by the appro-
priate ethics committee and have therefore been performed in 
accordance with the ethical standards laid down in the 1964 Declaration 
of Helsinki and its later amendments. Participants signed informed 
consent form before their inclusion in the study. Ethical approval was 
obtained from the Scientific and Ethical Committee of the Medical 
Research Council of Hungary (10058–3/2019/EKU). 
2.2. Survey 
This study was part of a larger population health survey in Hungary 
(Baji et al., 2020). Here we focus on the modules used for the purpose of 
the analyses in this paper. The socio-demographic characteristics (age, 
sex, educational level, place of residence, household characteristics) of 
the participants were recorded in computer-assisted personal in-
terviews. The paper-based self-completed versions of the ICECAP-A, 
ICECAP-O, EQ-5D-3L and EQ-5D-5L questionnaires were completed by 
the respondents and these data were recorded subsequently in the 
electronic database. 
2.3. Main outcome variables 
2.3.1. ICECAP-A and ICECAP-O 
The ICECAP-A and ICECAP-O are measures of capability wellbeing 
developed for adults (of age 18 and over) and elderly people (of age 65 
and over), respectively. Both measures comprise five domains in which 
the statements are formulated in terms of ‘can have’ or ‘being able to’ 
and refer to ‘Attachment’ (have love, friendship and support), ‘Stability’ 
(feel settled and secure), ‘Achievement’ (achieve and progress in life), 
‘Enjoyment’ (experience enjoyment and pleasure), ‘Autonomy’ (be in-
dependent) in the ICECAP-A, and ‘Attachment’ (love and friendship), 
‘Security’ (thinking about the future without concern), ‘Role’ (doing 
things that make you feel valued), ‘Enjoyment’ (enjoyment and plea-
sure), ‘Control’ (independence) in the ICECAP-O. Respondents are asked 
to choose the statement out of the four levels for each domain that best 
describes their quality of life at the moment (full capability: level 4, no 
capability: level 1). A preference-based index score (1 – full capability; 
0 – no capability) can be calculated based on the responses. Tariffs for 
the ICECAP-A/-O are available only from the UK, therefore we used 
these tariffs to calculate the ICECAP-A and ICECAP-O index scores 
(Flynn et al., 2015; Coast et al., 2008). In this study, we applied the 
ICECAP-A in the age group of 18–64 years and the ICECAP-O in the age 
group of 65 and older. 
2.3.2. HAQ-DI 
The HAQ-DI is a 2-page questionnaire that assesses the respondent’s 
level of functional ability over the past week in 20 questions (Bruce and 
Fries, 2003). The questions are grouped into eight categories (dressing 
and grooming, rising, eating, walking, hygiene, reach, grip, usual ac-
tivities). Responses can be provided on a 0–3 scale (0-without any dif-
ficulty, 1-with some difficulty, 2-with much difficulty, 3-unable to do). 
In addition, specific aids or devices utilized for assistance, as well as help 
needed from another person (aids/help) are also identified. To calculate 
HAQ-DI score, we applied the alternative scoring method, i.e. the score 
of the categories were not corrected for the use of devices or assistance 
(Ornbjerg et al., 2020). The worst component score defined the score of 
the category and the average of the eight categories was calculated 
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(range 0–3). 
2.3.3. EQ-5D-3L and EQ-5D-5L 
The EQ-5D-3L is a generic health status measure that consists of two 
parts: the EQ-5D descriptive system and a visual analogue scale (EQ 
VAS) (EuroQol, 1990). The descriptive part covers five domains of 
health (mobility, self-care, usual activities, pain/discomfort, anx-
iety/depression). Respondents are asked to indicate the problem level 
they have in each domain on a 3-level scale (1-no, 2-some/moderate, 
3-unable/extreme). The more recent EQ-5D-5L has the same construct, 
however with a 5-level response scale (1-no, 2-slight, 3-moderate, 4-se-
vere, 5-unable/extreme) (Herdman et al., 2011). These responses can be 
converted into a preference-based index score reflecting the utility of the 
health status from the societal perspective. Although measurement 
properties of the EQ-5D-5L are superior to EQ-5D-3L, given the huge 
amount of accumulated data with this latter instrument in the past 25 
years, we used both versions to ensure comparability (Thompson and 
Turner, 2020). Due to the lack of country-specific tariffs for Hungary at 
the time of the study, we used that of the UK and England to calculate 
the EQ-5D-3L (range: − 0.594 ─ 1) and EQ-5D–5L index scores (range: 
− 0.285 ─ 1), respectively, in which 1 indicates full health and 0 in-
dicates death, while negative scores refer to health states that are 
considered to be worse than death (Devlin et al., 2018; Dolan, 1997). 
The EQ VAS records the respondent’s self-rated health on a 0–100 scale 
with anchors ‘The best health you can imagine’ and ‘The worst health 
you can imagine’. 
2.3.4. Self-reported MSK problems in the European Health Interview Survey 
(EHIS) 
The EHIS is conducted every five years and collects data on the 
health status of the population among the EU member states (Eurostat 
European Health, 2020). The following set of questions of the EHIS were 
selected for our study: ‘Do you have difficulty walking 500 m on level 
ground without the use of any aid?’ (no/some/a lot of difficulty/cannot 
do at all or unable to do); ‘Do you have difficulty in walking up or down 
12 steps?’ (no/some/a lot of difficulty/cannot do at all or unable to do). 
Questions about self-reported presence of MSK diseases of the EHIS were 
also applied: ‘Low back disorder or other chronic back defect’, ‘Neck 
disorder or other chronic neck defect’, ‘Arthrosis’ (we have specified this 
item for hip and knee arthrosis, separately) and ‘Osteoporosis’. For each 
condition, respondents were asked to indicate whether a.) the condition 
have been present in the past 12 months, b.) was diagnosed by a medical 
doctor and c.) the respondent has taken medications for the condition 
based on medical advice. 
2.3.5. Identification of participants with MSK disorders 
We considered the HAQ-DI (response levels and index score), 
Mobility domain of the EQ-5D-3L/-5L (response level) and the questions 
of EHIS (levels of self-reported walking problems, self-reported presence 
of MSK disorders (such as neck/back/low back defects, hip/knee 
arthrosis, or osteoporosis) to identify people living with MSK health 
problems in the population. 
2.4. Statistical analysis 
Descriptive statistics were performed. Subgroup comparisons were 
carried out by ANOVA tests. Spearman’s rho correlation coefficients 
were calculated between continuous variables. In all types of analysis, a 
5% significance level was applied. The strength of correlation co-
efficients was assessed as follows: <0.1 trivial; 0.11–0.3 small; 0.31–0.5 
moderate; 0.51–0.7 high; 0.71–0.9 very high; and >0.9 nearly perfect 
(Hopkins, 2002). Ordinary least square (OLS) regression analysis was 
carried out to explore association between ICECAP-A/-O and HAQ-DI 
scores, controlling for socio-demographic characteristics (such as sex, 
age, education, settlement type, marital status, employment, net 
household income, household size). In all models ICECAP-A/-O index 
scores were dependent variables. In model 1–2, we in included only the 
HAQ-DI score, while in models 3–4, we also added EQ-5D-5L index and 
EQ VAS as health measures. (In models 5–6, all HAQ-DI domains, while 
in models 7–8 EQ-5D-5L domains were added to the models as inde-
pendent variables.) Analysis was carried out in SPSS Statistics 25. 
3. Results 
Altogether 5439 households were approached during the recruit-
ment but in 1548 cases (28.5%) nobody was at home. Out of the 3891 
invites, 1388 individuals (35.7%) refused to participate, 468 (12.0%) 
were younger than 18 years and 12 participants (0.3%) quitted during 
the study. A total of 2023 interviews (52.0%) were completed. Pre-
defined quotas for representativeness were fulfilled. Two respondents 
were excluded due to missing data on the ICECAP-A, hence 2021 in-
dividuals were included in the analyses. 
3.1. Sample characteristics 
Full details of the sample, including population normative data with 
the ICECAP-A and –O have been published elsewhere (Baji et al., 2020). 
In brief, the average (S.D.) age of the total sample was 48.7 (17.9) years 
and it was 41.6 (13.1) years in age-group 18–64 (N = 1,568, 77.6%) and 
73.3 (7.0) years in age group ≥65 (N = 453, 22.4%). In age-group 
18–64, the average (S.D.) EQ-5D-3L, EQ-5D-5L index, EQ VAS and 
ICECAP-A scores were 0.924 (0.164), 0.950 (0.119), 85.6 (14.9) and 
0.894 (0.126), respectively; while these scores were 0.716 (0.245), 
0.804 (0.196), 67.2 (17.8) and 0.828 (0.150) in age group ≥65. Both 
ICECAP-A and ICECAP-O index scores showed a decreasing tendency 
with age (Fig. 1A). 
Population norms with the HAQ-DI are provided in Table 1 and the 
distribution of answers on the HAQ-DI domains are presented in Table 2. 
The HAQ-DI index score of the total sample was on average (S.D.) 0.138 
(0.390); while in subgroups of age 18–64 and ≥ 65 years it was 0.052 
(0.253) and 0.463 (0.586), respectively. The number (%) of respondents 
with HAQ-DI score of 0 was 1427 (91.0%) and 200 (55.8%) in the two 
age groups, respectively. HAQ-DI index score differed significantly by 
age-groups (Fig. 1B), educational level, employment status, marital 
status and household income level, but not by sex or settlement type. 
Mean HAQ-DI scores by socio-demographic characteristics for age 
groups 18–64 and ≥ 65 years are presented separately in Online 
Resource 1. 
3.2. Relationship between ICECAP-A/-O and HAQ-DI measurement tools 
Both the ICECAP-A and ICECAP-O average index scores were 
inversely associated with HAQ-DI problem levels (with some exceptions 
on the most severe HAQ-DI levels, where sample sizes were very low, i.e. 
varied from 2 to 17 respondents) and the difference across levels was 
significant (p < 0.01) in all the eight HAQ-DI domains (Table 2). 
Correlations between both the domains and index scores of the HAQ- 
DI and ICECAP-A/-O were significant (p = 0.0000) (Table 3). The cor-
relations between the HAQ-DI score and both ICECAP-A/-O index scores 
were moderate, but it was bordering on high in the case of ICECAP-O (r 
= − 0.496) and bordering on low in the case of ICECAP-A (r = − 0.303). 
Domain-level correlations with the HAQ-DI were the weakest in the 
‘Attachment’ domain of the ICECAP-A and the strongest in the 
‘Achievement’. In the case of ICECAP-O, also the ‘Attachment’ showed 
the weakest domain-level correlations with HAQ-DI, and the strongest 
was found in the ‘Role’ domain (which is the counterpart of the ICECAP- 
A ‘Achievement’ domain). 
3.3. ICECAP-A/-O and HAQ-DI scores by self-reported MSK health 
Results are presented in Table 4. Both the ICECAP-A and ICECAP-O 
index scores differed significantly across all the observed subgroups. 
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As walking problem levels increased, the average ICECAP-A/-O scores 
decreased indicating a worsening capability wellbeing, with a few ex-
ceptions (ICECAP-A: ‘unable to walk 500 m … ‘, ‘unable to walk up or 
down 12 steps’; ICECAP-O: ‘unable to walk 500 m … ‘). 
With respect to self-reported MSK diagnoses, both ICECAP-A and –O 
scores were higher (better status) for respondents who reported no MSK 
diagnosis compared to those who reported to have medically confirmed 
MSK diagnosis. HAQ-DI score showed similar patterns. 
3.4. Regression 
Regression results are presented in Online Resource 2. In Model 1 
and 2 HAQ-DI scores were significantly (negatively) associated with 
ICECAP-A and ICECAP-O index scores (with marginal effects of − 0.149 
and − 0.123, respectively). However, when we include EQ-5D-5L index 
and EQ VAS in the models (Model 3 and 4), the HAQ-DI score is no 
longer significant (while EQ-5D-5L index and EQ VAS were significantly 
associated with the ICECAP-A/-O scores). Model 5 indicates that none of 
the HAQ-DI domains were associated with the ICECAP-A score, while in 
Model 6, ‘Dressing’, ‘Walking’ and ‘Hygiene’ were found to be associ-
ated with the ICECAP-O score at a 10% significance level. Models 7 and 
8 showed that ‘Pain/discomfort’ and ‘Anxiety/depression’ EQ-5D-5L 
domains were significantly associated with both ICECAP-A and –O 
index scores, while ‘Usual activities’ was associated with the ICECAP-O 
index score. 
4. Discussion 
We have assessed capability wellbeing measured by the ICECAP-A 
(age group 18–64) and ICECAP-O (age group 65 and over) in relation 
to MSK health in a cross-sectional survey among the general adult 
population of Hungary. Both the ICECAP-A and ICECAP-O index scores 
were lower as problems in physical functioning (HAQ-DI) and mobility 
(EQ-5D-3L/-5L) and on the relevant questions of the EHIS question-
naire) occurred. Correlations between the ICECAP-A/-O index and HAQ- 
DI scores were moderate, but it was stronger in the case of ICECAP-O. 
Fig. 1. Average ICECAP-A (18–64 years), ICECAP-O (65 years and over) and HAQ-DI index scores by sex and age-groups.  
Table 1 
Characteristics of the sample (N = 2021) and population norms for the HAQ-DI 
index score.   
N % HAQ-DI index score, 
mean (S.D.) 
Sex   P = 0.204 
Woman 1013 50.1% 0.15 (0.4) 
Man 1008 49.9% 0.13 (0.38) 
Age, years   P ¼ 0.000 
18-24 208 10.3% 0.01 (0.09) 
25-34 308 15.2% 0.02 (0.18) 
35-44 386 19.1% 0.04 (0.26) 
45-54 332 16.4% 0.04 (0.2) 
55-64 334 16.5% 0.13 (0.37) 
65-74 267 13.2% 0.26 (0.41) 
75-84 145 7.2% 0.58 (0.64) 
85+ 41 2.0% 1.05 (0.78) 
Education   P ¼ 0.000 
Primary 844 41.8% 0.24 (0.51) 
Secondary 768 38.0% 0.07 (0.25) 
Tertiary 409 20.2% 0.07 (0.26) 
Paid work   P ¼ 0.000 
No 734 36.3% 0.33 (0.57) 
Yes 1287 63.7% 0.03 (0.13) 
Settlement type   P = 0.105 
Budapest (capital) 399 19.7% 0.1 (0.28) 
Town 1060 52.4% 0.14 (0.4) 
Village 562 27.8% 0.16 (0.43) 
Married/partner   P ¼ 0.000 
No 783 38.7% 0.22 (0.5) 
Yes 1238 61.3% 0.09 (0.29) 
Per capita net income category 
(missing N ¼ 678)   
P ¼ 0.000 
1st quintile 271 20.2% 0.21 (0.47) 
2nd quintile 327 24.3% 0.12 (0.35) 
3rd quintile 312 23.2% 0.2 (0.45) 
4th quintile 232 17.3% 0.07 (0.22) 
5th quintile 201 15.0% 0.05 (0.2) 
Note: Subgroups were compared by ANOVA tests. 
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We observed also lower ICECAP-A/-O index scores in the presence of 
self-reported MSK diagnosis than in its absence. Regression analysis 
revealed that HAQ-DI score was a significant determinant of the 
ICECAP-A/-O index scores indicating that physical functioning plays 
substantial role in capability wellbeing. Nonetheless, HAQ-DI score 
(physical functioning) was no longer significant when it was controlled 
for the EQ-5D-5L (general health status). 
To the best our knowledge, this has been the first study to assess MSK 
health and capability wellbeing of adults in a sample representative for 
the general population. It has also been the first to analyze the associ-
ations of the HAQ-DI functional disability measure with the ICECAP-A 
and ICECAP-O capability wellbeing measures. 
Before we discuss our findings in the light of the available literature, 
some limitations of our study have to be noted. The prevalence of MSK 
health problems was low in the age group 18–64, which needs to be 
considered when interpreting the ICECAP-A results. We collected self- 
reported data, therefore we could not compare participants’ responses 
with medical records to check their validity. This drawback is especially 
relevant for the self-reported diagnosis, which might be influenced by 
various individual factors such as socio-demographics, physical and 
mental health status. We reached only few respondents in the worst MSK 
health states, hence further targeted studies are needed to test this 
relationship for the most severe cases. We used UK values to calculate 
ICECAP-A and ICECAP-O index scores as these were the only available 
value sets at the time of the study. Similarly, the tariffs of UK and En-
gland were used to calculate the EQ-5D-3L and EQ-5D-5L index scores, 
respectively, although there has been some controversy about this latter 
(NICE, 2019; van Hout et al., 2020 ). We used the alternative scoring 
method of HAQ-DI due to its simplicity and common use in clinical 
practice (Ornbjerg et al., 2020). The cross-sectional design of the study 
did not allow us to assess the measures in terms of responsiveness to 
changes. These shortcomings are suggested to be addressed in future 
studies. 
In previous ICECAP-A/-O studies involving (partially representative 
or) selected samples of the general population, physical functioning was 
assessed by functional independence measures or was approached by 
generic health status measures. Hackert et al. found moderate correla-
tion between ICECAP-O and the Barthel Index in an online survey among 
the elderly general population of the UK and in a sample of social care 
users (Hackert et al., 2017, 2019). Makai et al. reported strong corre-
lation between the Instrumental Activities of Daily Living (IADL) scale 
and the ICECAP-O index scores in a group of post-hospitalised older 
people in the Netherlands (Makai et al., 2013). Our findings with the 
HAQ-DI measure support the partial overlap and complementarity be-
tween physical functioning and capability wellbeing. The literature is far 
richer regarding the associations between the ICECAP-A/-O and the 
EQ-5D-3L/-5L among the general public (Afentou and Kinghorn, 2020; 
Proud et al., 2019; Cleland et al., 2019). Our results on the relationship 
between the ICECAP-A/-O and the ‘mobility’ domain and index scores of 
the EQ-5D-3L/-5L are in line with and strengthen the results of prece-
dent studies. 
The ICECAP-A/-O have been used in relatively few MSK disorders 
(falls prevention cohort, knee/hip osteoarthritis, hip fracture, arthritis 
as a diagnosis group) (Mitchell et al., 2013, 2015; Davis et al., 2012, 
2013, 2015, 2017; Parsons et al., 2014; Keeley et al., 2015, 2016; Wil-
liams et al., 2016; Milte et al., 2018). Only some of them analyzed their 
associations with condition-specific measures. Mitchell et al. (2013) 
explored the predictive ability of the Western Ontario and McMaster 
Universities Osteoarthritis Index (WOMAC) in relation to capability 
wellbeing (ICECAP-O), involving a group of patients with knee or hip 
osteoarthritis (Mitchell et al., 2013). Like the HAQ-DI in our survey, the 
WOMAC showed significant association with the ICECAP-O. However, 
the ‘Attachment’ ICECAP-O domain showed no significant relationship 
with any WOMAC category, just as in our sample the ‘Attachment’ 
domain showed the weakest correlation with the HAQ-DI score. Mitchell 
et al. (2015) highlighted that severity level of arthritis (as measured by 
the Arthritis Impact Measurement Scales 2‒Short Form) was a decisive 
factor in the deterioration of capabilities (ICECAP-A) (Mitchell et al., 
2015). In our survey, the worsening of ICECAP-A/-O by HAQ-DI levels 
seems to support the importance of disease severity in relation to 
Table 2 
Mean ICECAP-A/-O index scores by HAQ-DI domains.  
HAQ-DI 
domains 
Age-group 18-64 Age-group 65 and over 
N % ICECAP-A, 
mean (SD) 
N % ICECAP-O, 
mean (SD) 
Dressing & 
grooming   
P = 0.000   P = 0.000 
without any 
difficulty 
1523 97.1% 0.90 (0.12) 336 74.2% 0.86 (0.12) 
with some 
difficulty 
32 2.0% 0.72 (0.16) 94 20.8% 0.77 (0.14) 
with much 
difficulty 
7 0.4% 0.62 (0.22) 17 3.8% 0.57 (0.16) 
unable to do 6 0.4% 0.5 (0.15) 6 1.3% 0.46 (0.28) 
Arising   P ¼ 0.000   P ¼ 0.000 
without any 
difficulty 
1500 95.7% 0.90 (0.12) 305 67.3% 0.87 (0.12) 
with some 
difficulty 
53 3.4% 0.74 (0.17) 122 26.9% 0.78 (0.14) 
with much 
difficulty 
8 0.5% 0.73 (0.17) 21 4.6% 0.6 (0.21) 
unable to do 7 0.4% 0.54 (0.16) 5 1.1% 0.59 (0.21) 
Eating   P ¼ 0.000   P ¼ 0.000 
without any 
difficulty 
1543 98.4% 0.90 (0.12) 364 80.4% 0.85 (0.13) 
with some 
difficulty 
16 1.0% 0.72 (0.19) 70 15.5% 0.74 (0.17) 
with much 
difficulty 
2 0.1% 0.8 (0.16) 10 2.2% 0.64 (0.19) 
unable to do 7 0.4% 0.53 (0.16) 9 2.0% 0.68 (0.18) 
Walking   P ¼ 0.000   P ¼ 0.000 
without any 
difficulty 
1499 95.6% 0.90 (0.12) 282 62.3% 0.87 (0.12) 
with some 
difficulty 
49 3.1% 0.74 (0.18) 134 29.6% 0.78 (0.14) 
with much 
difficulty 
14 0.9% 0.76 (0.17) 28 6.2% 0.65 (0.18) 
unable to do 6 0.4% 0.54 (0.14) 9 2.0% 0.68 (0.24) 
Hygiene   P ¼ 0.000   P ¼ 0.000 
without any 
difficulty 
1511 96.4% 0.90 (0.12) 279 61.6% 0.87 (0.12) 
with some 
difficulty 
30 1.9% 0.73 (0.13) 102 22.5% 0.79 (0.13) 
with much 
difficulty 
11 0.7% 0.67 (0.18) 29 6.4% 0.75 (0.21) 
unable to do 16 1.0% 0.68 (0.21) 43 9.5% 0.67 (0.18) 
Reach   P ¼ 0.000   P ¼ 0.000 
without any 
difficulty 
1492 95.2% 0.90 (0.12) 279 61.6% 0.87 (0.12) 
with some 
difficulty 
58 3.7% 0.76 (0.15) 127 28.0% 0.79 (0.14) 
with much 
difficulty 
7 0.4% 0.66 (0.19) 30 6.6% 0.67 (0.19) 
unable to do 11 0.7% 0.57 (0.15) 17 3.8% 0.69 (0.17) 
Grip   P ¼ 0.000   P ¼ 0.000 
without any 
difficulty 
1543 98.4% 0.9 (0.12) 360 79.5% 0.85 (0.13) 
with some 
difficulty 
15 1.0% 0.68 (0.2) 77 17.0% 0.75 (0.17) 
with much 
difficulty 
2 0.1% 0.8 (0.16) 10 2.2% 0.66 (0.18) 
unable to do 8 0.5% 0.56 (0.2) 6 1.3% 0.65 (0.11) 
Activities   P ¼ 0.000   P ¼ 0.000 
without any 
difficulty 
1484 94.6% 0.90 (0.12) 263 58.1% 0.87 (0.12) 
with some 
difficulty 
60 3.8% 0.76 (0.15) 127 28.0% 0.8 (0.14) 
with much 
difficulty 
13 0.8% 0.67 (0.17) 36 7.9% 0.72 (0.15) 
unable to do 11 0.7% 0.59 (0.21) 27 6.0% 0.65 (0.21) 
Note: Subgroups were compared by ANOVA tests. 
M. Péntek et al.                                                                                                                                                                                                                                 
Musculoskeletal Science and Practice 55 (2021) 102420
6
capabilities. Taking medicine for MSK problems (which can be consid-
ered as a rough proxy indicator of disease severity) was associated also 
with worse ICECAP-A/-O scores in most of the cases. Hence it is 
worthwhile investigating further by using condition-specific measures 
to define how disease severity can shape capability wellbeing in 
different MSK disorders. 
With the exception of one study (Mitchell et al., 2013), the EQ-5D 
was applied alongside the ICECAP-A/-O in the MSK studies and the 
complementarity of these measures have been proved. Also, it has been 
revealed that the relationship between change in health status (EQ-5D) 
and change in capabilities (ICECAP-A/-O) is not straightforward and 
may vary substantially across MSK patient groups (Parsons et al., 2014; 
Davis et al., 2015; Keeley et al., 2015). However, all but one (Mitchell 
et al., 2015) studies used the EQ-5D-3L version. Moreover, analyses on 
the EQ-5D domains’ level was reported only in one MSK study (Milte 
et al., 2018). Therefore, our research has been an important step towards 
filling the knowledge gap about the relationship between the EQ-5D-5L 
version and ICECAP-A/-O measures in the context of MSK health. 
Regarding the generalizability of our results, we believe that our 
findings cannot be transferred to other jurisdictions without adjustments 
as the health status of the general population varies significantly across 
countries (Janssen et al., 2019; Zrubka et al., 2019). Rather than 
involving well-defined patient groups, we focused on self-reported MSK 
health status, hence the generalizability of our data about specific MSK 
diseases should be investigated in future studies. This is particularly 
relevant in age group 18–64 where the rate of individuals with MSK 
problems was low. We would especially be interested in matching our 
results to studies in rheumatoid arthritis where the HAQ-DI is a core 
measure. 
Our results have important implications for clinical practice and 
health economic evaluations alike. The ICECAP-A/-O capture important 
additional aspects of quality of life (e.g. attachment) that would remain 
invisible for the HAQ-DI. Moreover, the moderate associations with the 
EQ-5D-5L indicate that the ICECAP-A/-O alone may not entirely cover 
all aspects of health. Therefore, the use of additional physical func-
tioning and health status measures alongside the ICECAP-A/-O is rec-
ommended to assess disease burden or treatment effects. Caution is 
required when using HAQ-DI for estimating capability wellbeing scores 
in the lack of measured ICECAP-A/-O data and, if available, it is pref-
erable to use the EQ-5D-5L for the estimations. 
5. Conclusions 
Our study confirmed that MSK health problems could play a signif-
icant role in the capability wellbeing of individuals. The use of ICECAP- 
A/-O, in addition to the physical functioning and health status measures 
is encouraged to get a broader picture of the burden of MSK diseases and 
effectiveness of interventions. Our results in terms of the self-reported 
MSK problems of the general population are encouraging for those 
interested in using the ICECAP-A/-O instruments in MSK diseases. 
Disease-specific studies are much needed to explore the determinants of 
capability wellbeing across diverse MSK conditions. 
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Spearman’s correlations between HAQ-DI and ICECAP-A/-O domains and index scores.  










HAQ dressing − 0.197 − 0.147 − 0.178 − 0.203 − 0.164 − 0.217 
HAQ arising − 0.190 − 0.143 − 0.162 − 0.230 − 0.164 − 0.228 
HAQ eating − 0.118 − 0.089 − 0.124 − 0.147 − 0.083 − 0.149 
HAQ walking − 0.208 − 0.122 − 0.158 − 0.216 − 0.144 − 0.223 
HAQ hygiene − 0.194 − 0.145 − 0.167 − 0.238 − 0.173 − 0.235 
HAQ reach − 0.215 − 0.153 − 0.167 − 0.242 − 0.182 − 0.247 
HAQ grip − 0.150 − 0.097 − 0.145 − 0.152 − 0.134 − 0.161 
HAQ activity − 0.244 − 0.130 − 0.178 − 0.236 − 0.181 − 0.255 
HAQ-DI index score − 0.282 − 0.184 − 0.208 − 0.284 − 0.222 − 0.303 




ICECAP-O Security ICECAP-O Role ICECAP-O Enjoyment ICECAP-O Control ICECAP-O index 
score 
HAQ dressing − 0.225 − 0.316 − 0.433 − 0.304 − 0.364 − 0.403 
HAQ arising − 0.249 − 0.284 − 0.390 − 0.290 − 0.343 − 0.396 
HAQ eating − 0.191 − 0.261 − 0.345 − 0.294 − 0.270 − 0.335 
HAQ walking − 0.205 − 0.316 − 0.421 − 0.298 − 0.367 − 0.418 
HAQ hygiene − 0.229 − 0.309 − 0.438 − 0.342 − 0.337 − 0.433 
HAQ reach − 0.194 − 0.2096 − 0.372 − 0.318 − 0.316 − 0.390 
HAQ grip − 0.168 − 0.235 − 0.300 − 0.264 − 0.296 − 0.326 
HAQ activity − 0.184 − 0.331 − 0.404 − 0.327 − 0.332 − 0.429 
HAQ-DI index score − 0.252 − 0.373 − 0.489 − 0.387 − 0.400 − 0.496 
Note: for all correlations, P = 0.0000. 
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Péntek, Zsombor Zrubka, Ágota Dobos, Miklós Farkas and Petra Baji. 
The first draft of the manuscript was written by Márta Péntek, Miklós 
Farkas and Petra Baji and all authors critically revised for important 
intellectual content and commented on previous versions of the manu-
script. All authors read and approved the final manuscript agreed to be 
accountable for all aspects of the work in ensuring that questions related 
to the accuracy or integrity of any part of the work are appropriately 
investigated and resolved. 
Declaration of competing interest 
In connection with writing this article, PB, ÁD and MP received grant 
support from the Higher Education Institutional Excellence Program of 
the Ministry for Innovation and Technology in the framework of the 
Financial and Public Services research project (NKFIH-1163-10/2019) 
at Corvinus University of Budapest; and PB, MF, LG and MP received 
grant support also in the third year (TKP2020-IKA-02) of the same 
research project. The work of MP and LG was supported by Project no. 
2019–1.3.1-KK-2019-00007 that has been implemented with the sup-
port provided from the National Research, Development and Innovation 
Fund of Hungary, financed under the 2019–1.3.1-KK funding scheme. In 
connection with this project, ZZ has received funding from the European 
Research Council (ERC) under the European Union’s Horizon 2020 
research and innovation programme (grant agreement No 679681). MP 
is member of the EuroQol Group, a not-for-profit organization that de-
velops and distributes instruments that assess and value health. Other 
authors declare that they have no conflict of interest. 
Acknowledgement 
Authors are grateful for Tamás Cserni (Msc student, Corvinus Uni-
versity of Budapest) for his assistance with the data analysis. 
Table 4 
Mean ICECAP-A/-O and HAQ-DI scores by self-reported mobility problems and musculoskeletal diagnoses.   
Age-group 18–64 years Age-group 65 years and over  
N % ICECAP-A score, 
mean (S.D.) 
HAQ-DI index 
score, mean (S.D.) 
N % ICECAP-O, 
mean (S.D.) 
HAQ-DI index score, 
mean (S.D.) 
Self-reported mobility problems         
Difficulty in walking 500 m on level ground 
without the use of any aid   
P ¼ 0.000 P ¼ 0.000   P ¼ 0.000 P ¼ 0.000 
No difficulty 1449 92.5% 0.91 (0.11) 0.01 (0.07) 222 49.1% 0.88 (0.12) 0.09 (0.21) 
Some difficulty 76 4.9% 0.75 (0.17) 0.36 (0.43) 158 35.0% 0.81 (0.13) 0.56 (0.44) 
A lot of difficulty 23 1.5% 0.66 (0.21) 1.02 (0.8) 54 11.9% 0.69 (0.18) 1.09 (0.74) 
Unable to do 19 1.2% 0.77 (0.22) 0.69 (1.19) 18 4.0% 0.71 (0.25) 1.6 (0.79) 
Difficulty in walking up or down 12 steps   P ¼ 0.000 P ¼ 0.000   P ¼ 0.000 P ¼ 0.000 
No difficulty 1420 90.6% 0.91 (0.11) 0.01 (0.07) 202 44.6% 0.89 (0.12) 0.19 (0.01) 
Some difficulty 93 5.9% 0.79 (0.17) 0.23 (0.33) 149 32.9% 0.82 (0.12) 0.4 (0.03) 
A lot of difficulty 42 2.7% 0.68 (0.19) 0.77 (0.75) 83 18.3% 0.73 (0.16) 0.66 (0.07) 
Unable to do 12 0.8% 0.71 (0.24) 1.14 (1.34) 19 4.2% 0.68 (0.25) 0.86 (0.2) 
EQ-5D-3L: Mobility (walking around)   P ¼ 0.000 P ¼ 0.000   P ¼ 0.000 P ¼ 0.000 
No problems 1386 88.6% 0.75 (0.18) 0.01 (0.05) 178 39.4% 0.9 (0.09) 0.21 (0.02) 
Some problems 176 11.2% 0.51 (0.23) 0.35 (0.55) 271 60.0% 0.79 (0.16) 0.63 (0.04) 
Confined to bed 3 0.2% 0.89 (0.13) 2.92 (0.14) 3 0.7% 0.51 (0.37) 0.07 (0.04) 
EQ-5D-5L: Mobility (walking around)   P ¼ 0.000 P ¼ 0.000   P ¼ 0.000 P ¼ 0.000 
No 1362 87.0% 0.92 (0.1) 0.01 (0.05) 152 33.6% 0.9 (0.1) 0.18 (0.01) 
Slight problems 138 8.8% 0.79 (0.16) 0.19 (0.37) 166 36.6% 0.84 (0.11) 0.41 (0.03) 
Moderate problems 40 2.6% 0.68 (0.18) 0.41 (0.45) 97 21.4% 0.77 (0.17) 0.56 (0.06) 
Severe problems 24 1.5% 0.65 (0.22) 1.16 (0.98) 37 8.2% 0.62 (0.19) 0.66 (0.11) 
Unable to walk 1 0.1% 0.37 (0) 0.01 (0.05) 1 0.2% 0.88 (0) konstant 
Self-reported musculoskeletal diagnosis in the 
past 12 months or currently         
Low back disorder or other chronic back 
defect   
P ¼ 0.000 P ¼ 0.000   P ¼ 0.000 P ¼ 0.000 
No 1125 71.7% 0.92 (0.1) 0.03 (0.21) 178 39.3% 0.87 (0.14) 0.5 (0.04) 
Yes, but not diagnosed 254 16.2% 0.87 (0.14) 0.03 (0.2) 92 20.3% 0.83 (0.15) 0.51 (0.05) 
Diagnosed but no medicine 47 3.0% 0.86 (0.14) 0.04 (0.11) 29 6.4% 0.83 (0.13) 0.54 (0.1) 
Diagnosed and medicine 142 9.1% 0.78 (0.17) 0.26 (0.5) 154 34.0% 0.78 (0.15) 0.67 (0.05) 
Neck disorder or other chronic neck defect   P ¼ 0.000 P ¼ 0.000   P ¼ 0.007 P ¼ 0.000 
No 1313 83.7% 0.91 (0.11) 0.04 (0.22) 317 70.0% 0.84 (0.15) 0.55 (0.03) 
Yes, but not diagnosed 175 11.2% 0.85 (0.16) 0.04 (0.14) 55 12.1% 0.84 (0.14) 0.47 (0.06) 
Diagnosed but no medicine 22 1.4% 0.82 (0.14) 0.20 (0.53) 13 2.9% 0.80 (0.09) 0.69 (0.19) 
Diagnosed and medicine 58 3.7% 0.73 (0.2) 0.39 (0.63) 68 15.0% 0.77 (0.14) 0.72 (0.09) 
Arthrosis of the hip   P ¼ 0.000 P ¼ 0.000   P ¼ 0.000 P ¼ 0.000 
No 1363 86.9% 0.90 (0.12) 0.03 (0.16) 307 67.8% 0.84 (0.14) 0.53 (0.03) 
Yes, but not diagnosed 146 9.3% 0.88 (0.14) 0.06 (0.33) 47 10.4% 0.85 (0.16) 0.52 (0.08) 
Diagnosed but no medicine 12 0.8% 0.80 (0.20) 0.26 (0.65) 14 3.1% 0.76 (0.2) 0.76 (0.2) 
Diagnosed and medicine 47 3.0% 0.71 (0.2) 0.61 (0.79) 85 18.8% 0.77 (0.15) 0.64 (0.07) 
Arthrosis of the knee   P ¼ 0.000 P ¼ 0.000   P ¼ 0.005 P ¼ 0.000 
No 1315 83.9% 0.91 (0.11) 0.03 (0.2) 280 61.8% 0.84 (0.14) 0.54 (0.03) 
Yes, but not diagnosed 156 9.9% 0.86 (0.15) 0.08 (0.37) 45 9.9% 0.85 (0.18) 0.34 (0.05) 
Diagnosed but no medicine 31 2.0% 0.83 (0.18) 0.14 (0.37) 22 4.9% 0.76 (0.22) 0.61 (0.13) 
Diagnosed and medicine 66 4.2% 0.79 (0.17) 0.30 (0.52) 106 23.4% 0.80 (0.14) 0.69 (0.07) 
Osteoporosis   P ¼ 0.000 P ¼ 0.000   P ¼ 0.000 P ¼ 0.000 
No 1386 88.4% 0.90 (0.12) 0.05 (0.24) 339 74.8% 0.84 (0.14) 0.52 (0.03) 
Yes, but not diagnosed 144 9.2% 0.87 (0.15) 0.04 (0.19) 42 9.3% 0.86 (0.14) 0.36 (0.06) 
Diagnosed but no medicine 7 0.4% 0.81 (0.18) 0.18 (0.34) 11 2.4% 0.76 (0.18) 0.60 (0.18) 
Diagnosed and medicine 31 2.0% 0.72 (0.2) 0.39 (0.64) 61 13.5% 0.75 (0.17) 0.79 (0.1) 
Note: Subgroups were compared by ANOVA tests. 
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Supplementary data to this article can be found online at https://doi. 
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